Senior Vice President, Process Development and Manufacturing · Vaxcyte, Inc. (PCVX)

Paul Sauer

A named executive officer of Vaxcyte in every fiscal year CompBrief holds from FY2019 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$2,354,242

Salary $390,938Stock awards $247,900Bonus $27,365

FY2021: $1,087,630

5th of 5 named executive officers at Vaxcyte by FY2022 total.

5 named officers on file for Vaxcyte, FY2022

Paul Sauer’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • PCVX’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Vaxcyte’s whole pay program stands against its peers

  • Vaxcyte’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PCVX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2023 (DEF 14A).

Free

Get Paul Sauer’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Paul Sauer compensation by year

Vaxcyte Summary Compensation Table · all 4 fiscal years held
In US dollars, as Vaxcyte reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022
Salary$300,000$310,500$375,000$390,938
Bonus$0$0$0$27,365
Stock awards$0$0$0$247,900
Option awards$41,705$469,608$561,692$1,497,386
Non-equity incentive$90,000$124,410$150,938$177,877
Pension and deferred compensation$0$0$0$0
All other$0$0$0$12,776
Total$431,705$904,518$1,087,630$2,354,242

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vaxcyte, Inc. DEF 14A filed April 28, 2023, accession 0001193125-23-123940, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Vaxcyte, Inc. filed document, accession 0001193125-23-123940. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2023.

$432K
$905K
$1.1M
$2.4M
FY19
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU7,500$359,625—
Option20,559—$5.35
Option23,334—$20.93
Option48,750—$24.79
Option15,000—$47.95
Option618—$2.03

Per the Outstanding Equity Awards at Fiscal Year-End table in Vaxcyte, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Vaxcyte’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Grant PickeringChief Executive Officer$13,661,941
Jim WassilExecutive Vice President and Chief Operating Officer$6,991,203
Andrew GuggenhimePresident and Chief Financial Officer$6,902,093
Mikhail EydelmanSenior Vice President, General Counsel and Corporate Secretary$5,013,144
Paul Sauer · this pageSenior Vice President, Process Development and Manufacturing$2,354,242

The full Vaxcyte compensation record

free company brief

This page is one person within Vaxcyte's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Vaxcyte's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Paul Sauer's compensation dossier · One-time report. No refunds.